Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 390 citing Goodrich: Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow.... (0.08 sec) 

Reconstitution of cellular immunity against cytomegalovirus in recipients of …


EA Walter, PD Greenberg, MJ Gilbert, RJ … - New England Journal …, 1995 - content.nejm.org
ELIZABETH A. WALTER, MD, PHILIP D. GREENBERG, MD, MARK J. GILBERT, MD, ROSALYNDE
J. FINCH, MSC., KÄTHE S. WATANABE, MSC., E. DONNALL THOMAS, MD, AND STANLEY
R. RIDDELL, MD Abstract Background. Cytomegalovirus (CMV) dis- ease in ...
Cited by 1085 - Related articles - BL Direct - All 7 versions

Bone marrow transplants from unrelated donors for patients with chronic myeloid …

- ufl.edu [PDF] 
JA Hansen, TA Gooley, PJ Martin, F … - The New England …, 1998 - nejm.highwire.org
Results The median follow-up was 5 years (range, 1.2 to 10.1). Graft failure occurred in 5 percent
of patients who could be evaluated. Acute graft-versus-host disease of grade III or IV severity
was observed in 35 percent of patients who received HLA-matched transplants, and the ...
Cited by 509 - Related articles - BL Direct - All 9 versions

Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus …

- hematologylibrary.org [PDF] 
M Boeckh, TA Gooley, D Myerson, T … - …, 1996 - bloodjournal.hematologylibrary.org
. reserved Hematology; all rights Copyright 2007 by The American Society of Suite 200, Washington
DC 20036. semimonthly by the American Society of Hematology, 1900 M St, NW, Blood (print
ISSN 0006-4971, online ISSN 1528-0020), is published ... For personal use only. at ...
Cited by 376 - Related articles - BL Direct - All 4 versions

Optimizing outcome after unrelated marrow transplantation by comprehensive …

- hematologylibrary.org
EW Petersdorf, TA Gooley, C Anasetti, PJ … - …, 1998 - bloodjournal.hematologylibrary.org
In unrelated marrow transplantation, the benefit of matching class II HLA-DRB1 and DQB1 alleles
of the donor and recipient is well documented. Little is known about the clinical relevance of
matching for class I HLA-A, B, and C alleles. We used DNA-amplification methods to ...
Cited by 330 - Related articles - BL Direct - All 7 versions

Quantitation of cytomegalovirus: methodologic aspects and clinical applications

- nih.gov
M Boeckh, G Boivin - Clinical Microbiology Reviews, 1998 - Am Soc Microbiol
Cytomegalovirus (CMV) is an important pathogen in transplant recipients and human immunodeficiency
virus (HIV)-infected individuals. Major progress has been made in developing quantitative detection
methods for CMV in recent years. Due to their high sensitivity, these assays can detect ...
Cited by 323 - Related articles - BL Direct - All 5 versions

Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus …

- hematologylibrary.org [PDF] 
H Einsele, G Ehninger, H Hebart, KM … - …, 1995 - bloodjournal.hematologylibrary.org
. reserved Hematology; all rights Copyright 2007 by The American Society of Suite 200, Washington
DC 20036. semimonthly by the American Society of Hematology, 1900 M St, NW, Blood (print
ISSN 0006-4971, online ISSN 1528-0020), is published ... For personal use only. at ...
Cited by 321 - Related articles - BL Direct - All 7 versions

Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem …


HM Lazarus, ON Koc, SM Devine, P Curtin, RT … - Biology of Blood and …, 2005 - Elsevier
Mesenchymal stem cells (MSCs) are found in a variety of tissues, including human bone
marrow; secrete hematopoietic cytokines; support hematopoietic progenitors in vitro; and possess
potent immunosuppressive properties. We hypothesized that cotransplantation of culture- ...
Cited by 314 - Related articles - All 8 versions

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of …


E Gane, F Saliba, GJC Valdecasas, J O'Grady, MD … - The Lancet, 1997 - Elsevier
The Kaplan-Meier estimate of the 6-month incidence of CMV disease was 29 (18·9%) of 154
in the placebo group, compared with seven (4·8%) of 150 in the ganciclovir group (p<0·001).
In the high-risk group of seronegative recipients (R−) of seropositive livers (D+), incidence ...
Cited by 293 - Related articles - BL Direct - All 8 versions

Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk …


KA Marr, K Seidel, TC White, RA Bowden - The Journal of infectious …, 1999 - UChicago Press
Featured in US News & World Report "Common Cold Virus Alters Body's Genes" October
24, 2008 Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus
(RSV) Vaccines— Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given ...
Cited by 288 - Related articles - BL Direct - All 5 versions

VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular …

- bloodjournal.org [PDF] 
P Salven, S Mustjoki, R Alitalo, K Alitalo, S Rafii - Blood, 2002 - Am Soc Hematology
. Hematology; all rights reserved Copyright 2007 by The American Society of DC 20036. by the
American Society of Hematology, 1900 M St, NW, Suite 200, Washington Blood (print ISSN
0006-4971, online ISSN 1528-0020), is published semimonthly ... For personal use only. ...
Cited by 237 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google